MedTrace Logo

His Bundle Pacing Versus Right Ventricular Pacing

NCT04672408 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2025-04-09

No results posted yet for this study

Summary

This study will randomize cross-over periods of 6 months of right ventricular pacing and His bundle pacing in patients with baseline left ventricular ejection fraction (LVEF)\>40%. The primary outcome measure is LVEF.

Conditions

  • Pacing-Induced Cardiomyopathy

Interventions

DEVICE

His bundle pacing

Pacing with capture of the His bundle

DEVICE

Right ventricular pacing

Pacing from the right ventricular lead (septal or apical)

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Haran Burri, MD · University Hospital, Geneva

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2025-04-04
Completion
2025-04-04

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04672408 on ClinicalTrials.gov